日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

急性髓系白血病(AML)患者接受维奈托克治疗的入组标准、治疗模式和疗效:一项前瞻性队列研究

Wolach, Ofir; Levi, Itai; Nachmias, Boaz; Tavor, Sigal; Amitai, Irina; Ofran, Yishai; Ganzel, Chezi; Zuckerman, Tsila; Okasha, Doaa; Hellmann, Ilana; Tadmor, Tamar; Dally, Najib; Canaani, Jonathan; Stemer, Galia; Grunspan, Moshe; Berger, Adi Jacob; Frankel, Neta; Berelovich, Jenia; Bleterman, Alexandra; Barak, Moran; Cohen, Raanan; Moshe, Yakir

CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot study

CPX-351 +/- 吉妥珠单抗奥佐米星作为新诊断的、预后良好至中等风险、FLT3-ITD 阴性急性髓系白血病 (AML) 成人患者的诱导治疗:一项初步研究

Ganzel, Chezi; Frisch, Avraham; Wolach, Ofir; Moshe, Yakir; Krayem, Baher; Dor, Neta; Broide, Etti; Benayoun, Emmanuel; Rowe, Jacob M; Ofran, Yishai

Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission

对于携带NPM1突变的AML老年患者,在第二次缓解期进行异基因移植可改善复发后的预后。

Frisch, Avraham; Ganzel, Chezi; Ofran, Yishai; Krayem, Baher; Haran, Arnon; Vainstein, Vladimir; Aumann, Shlomzion; Even-Zohar, Noa Gross; Nachmias, Boaz

Successful Treatment with Daratumumab of a Patient with Monoclonal Lambda Light Chain Disease Presenting as Nephrotic Syndrome and Crescentic Glomerulonephritis

达雷妥尤单抗成功治疗一例以肾病综合征和新月体肾小球肾炎为首发症状的单克隆λ轻链病患者

Bnaya, Alon; Ganzel, Chezi; Shavit, Linda

Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study

阿司匹林治疗不适合接受强化化疗的急性髓系白血病患者:一项 II 期研究

Altman, Jessica K; Zuckerman, Tsila; Koprivnikar, Jamie; McCloskey, James; Kota, Vamsi; Keng, Michael; Frankfurt, Olga; Abaza, Yasmin; Bixby, Dale L; Emadi, Ashkan; Burch, Micah; Bhatnagar, Bhavana; Luger, Selina M; Percival, Mary-Elizabeth; Wolach, Ofir; Craig, Michael; Ganzel, Chezi; Roboz, Gail; Levi, Itai; Gourevitch, Anna; Flaishon, Liat; Tessler, Shoshi; Blumberg, Chen; Gengrinovitch, Stela; Ben Yakar, Ruth; Rowe, Jacob M

Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study

belantamab mafodotin 治疗复发/难治性多发性骨髓瘤的真实世界经验:一项多中心回顾性研究

Shragai, Tamir; Magen, Hila; Lavi, Noa; Gatt, Moshe; Trestman, Svetlana; Zektser, Miri; Ganzel, Chezi; Jarchowsky, Osnat; Berger, Tamar; Tadmor, Tamar; Leiba, Merav; Hertzog-Tzarfaty, Katrin; Horowitz, Netanel; Shapira, Michael; Varssano, David; Berger, Yoav; Frenkel, Shahar; Krauthammer, Mark; Avivi, Irit; Luttwak, Efrat; Cohen, Yael C

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA

以色列药品注册流程:卫生部内部讨论次数与EMA和/或FDA批准后变更之间的相关性

Hiayev, Stephany; Shacham-Shmueli, Einat; Berkovitch, Matitiahu; Weiss, Ilana; Ashkenazi, Shai; Vexberg, Michal Hirsch; Hershkowitz, Rami; Gorelik, Einat; Mayan, Haim; Steinmetz, Yehudit; Yanai, Noa Berar; Schlissel, Orly; Azem, Muhammad; Gutgold, Neriya; Shulman, Katerina; Divinsky, Milly; Yarom, Nirit; Vishkautzan, Alla; Ganzel, Chezi; Gatt, Moshe E; Arcavi, Lidia; Marom, Eli; Uziely, Biatrice; Zevin, Shoshana; Meirow, Hadar; Luxenburg, Osnat; Ainbinder, Denize

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

急性髓系白血病中通过流式细胞术测量的可测量残留病灶具有预后价值,且与基因组分析无关。

Ganzel, Chezi; Sun, Zhuoxin; Baslan, Timour; Zhang, Yanming; Gönen, Mithat; Abdel-Wahab, Omar I; Racevskis, Janis; Garrett-Bakelman, Francine; Lowe, Scott W; Fernandez, Hugo F; Ketterling, Rhett; Luger, Selina M; Litzow, Mark; Lazarus, Hillard M; Rowe, Jacob M; Tallman, Martin S; Levine, Ross L; Paietta, Elisabeth

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

通过单细胞测序鉴定复发性多发性骨髓瘤患者的耐药通路和治疗靶点

Yael C Cohen # ,Mor Zada # ,Shuang-Yin Wang # ,Chamutal Bornstein ,Eyal David ,Adi Moshe ,Baoguo Li ,Shir Shlomi-Loubaton ,Moshe E Gatt ,Chamutal Gur ,Noa Lavi ,Chezi Ganzel ,Efrat Luttwak ,Evgeni Chubar ,Ory Rouvio ,Iuliana Vaxman ,Oren Pasvolsky ,Mouna Ballan ,Tamar Tadmor ,Anatoly Nemets ,Osnat Jarchowcky-Dolberg ,Olga Shvetz ,Meirav Laiba ,Ofer Shpilberg ,Najib Dally ,Irit Avivi ,Assaf Weiner ,Ido Amit

CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials

急性髓系白血病(AML)诊断时出现中枢神经系统受累的情况很少见,且不影响治疗效果或生存期:来自11项ECOG-ACRIN试验的数据

Ganzel, Chezi; Lee, Ju-Whei; Fernandez, Hugo F; Paietta, Elisabeth M; Luger, Selina M; Lazarus, Hillard M; Cripe, Larry D; Douer, Dan; Wiernik, Peter H; Rowe, Jacob M; Tallman, Martin S; Litzow, Mark R